Dual roles of MYH9/NMHC IIA in cancer: molecular mechanisms, immune regulation, and therapeutic targeting potential

The myosin heavy chain 9 ( MYH9 ) gene encodes non-muscle myosin heavy chain IIA (NMHC IIA), a key effector linking the actin cytoskeleton, mechanical force generation, and signal transduction. The role of MYH9 in cancer is markedly dependent on cell type, gene dosage, subcellular localization, and molecular context. Although most studies have reported tumor-promoting effects, a limited number of in vivo genetic models support a tumor-suppressive role in specific settings, such as squamous cell carcinoma; p53 status may further influence the direction of this activity. Here, we review MYH9 structure, expression regulation, and the distinctions between its intracellular and extracellular forms. We critically compare evidence for its tumor-promoting and tumor-suppressive roles, distinguishing direct functional validation from preclinical associations and bioinformatic correlations. We further summarize how non-coding RNA-mediated regulation, proteostasis, and cytoskeletal remodeling relate to therapy resistance and discuss the direct and indirect effects of MYH9 on immune cells and the tumor microenvironment. Finally, we assess the translational potential of MYH9 in terms of isoform selectivity, tumor-specific delivery, normal-tissue toxicity, and combination therapy. Current evidence is insufficient to establish MYH9 as a clinically validated predictive biomarker for immunotherapy or as a broad-spectrum therapeutic target. Its clinical application will require mechanistically rigorous in vivo studies and prospective clinical validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-16
DOI
https://doi.org/10.3389/fonc.2026.2014746
Primary Topic
Cellular Mechanics and Interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dual roles of MYH9/NMHC IIA in cancer: molecular mechanisms, immune regulation, and therapeutic targeting potential

Zhuqiang Zhang, Qier Mu, Zhijun Li, Kaifeng Ji et al.
1 links
Frontiers in Oncology
Cellular Mechanics and Interactions
article

Dual roles of MYH9/NMHC IIA in cancer: molecular mechanisms, immune regulation, and therapeutic targeting potential

Zhuqiang Zhang, Qier Mu, Zhijun Li, Kaifeng Ji, Siqinhu Zhang
article en

Abstract

The myosin heavy chain 9 ( MYH9 ) gene encodes non-muscle myosin heavy chain IIA (NMHC IIA), a key effector linking the actin cytoskeleton, mechanical force generation, and signal transduction. The role of MYH9 in cancer is markedly dependent on cell type, gene dosage, subcellular localization, and molecular context. Although most studies have reported tumor-promoting effects, a limited number of in vivo genetic models support a tumor-suppressive role in specific settings, such as squamous cell carcinoma; p53 status may further influence the direction of this activity. Here, we review MYH9 structure, expression regulation, and the distinctions between its intracellular and extracellular forms. We critically compare evidence for its tumor-promoting and tumor-suppressive roles, distinguishing direct functional validation from preclinical associations and bioinformatic correlations. We further summarize how non-coding RNA-mediated regulation, proteostasis, and cytoskeletal remodeling relate to therapy resistance and discuss the direct and indirect effects of MYH9 on immune cells and the tumor microenvironment. Finally, we assess the translational potential of MYH9 in terms of isoform selectivity, tumor-specific delivery, normal-tissue toxicity, and combination therapy. Current evidence is insufficient to establish MYH9 as a clinically validated predictive biomarker for immunotherapy or as a broad-spectrum therapeutic target. Its clinical application will require mechanistically rigorous in vivo studies and prospective clinical validation.

Frontiers in OncologyVol. 16
Inner Mongolia People's Hospital (CN), Baotou Medical College (CN), Inner Mongolia Medical University (CN)
Good health and well-being
Cellular Mechanics and Interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon